Perspective
Our work in Perspective
-
Podcast: Essentially Medicine
Jakub Hlavka discusses numerous approaches to increase access to cell- and gene-therapies and how political will is essential to realize improvements in healthcare on the Essentially Medicine podcast.
Categorized in -
For the Sake of Kidney Patients, Vote No on Proposition 23
As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.
Categorized in -
Free COVID-19 Vaccines: Not Enough to Guarantee Acceptance, Especially Among Black Americans
The researchers find cost does matter when estimating willingness to get a COVID-19 vaccine, but it isn’t the whole story.
Categorized in -
Surprise Medical Bills Increase Costs for Everyone, Not Just for the People Who Get Them
About 12% of insurers’ U.S. spending on in- and out-of-network medical care goes to six types of providers that commonly submit surprise bills.
Categorized in -
BMJ: What Current and Missing Data Can Teach Us About Medication Errors
The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.
Categorized in -
NEJM: Competing Visions for the Future of Health Policy
Beyond Covid-19, two other health policy issues are poised to feature prominently in the 2020 U.S. elections: what role government should play in ensuring broad health insurance coverage, and how to cope with the lack of competition in many health care provider markets.
Categorized in -
Declaring the Vape Industry Illegal Will Only Drive It Underground
Declaring a multi-billion dollar industry illegal will only drive it underground. It will also make the health effects of vaping even more difficult to ascertain.
Categorized in -
Sharing Drug Rebates With Medicare Part D Patients: Why And How
The percentage of total Medicare Part D drug spending offset by rebates on branded drugs increased from 11% in 2010 to 25% in 2018.
Categorized in -
The COVID-19 Vaccine Model Needs to Prioritize ‘Superspreaders.’ Here is Why.
After taking care of essential workers, vaccinations should be given to the biggest transmitters of the virus – mostly the young – and only then to the most vulnerable.
Categorized in -
How To Boost Health Insurance Enrollment: Three Practical Steps That Merit Bipartisan Support
The authors explain how gaps in eligibility for federal assistance programs, perceptions of affordability, and administrative complexity create barriers that prevent millions of Americans from obtaining affordable coverage.
Categorized in